ApprovalTrail

Medical device licence · 67223 · Class 2

INFORM CYTOPLASMIC LAMBDA MRNA PROBE

Yes: licensed in Canada

Licence status Issued (active); first licensed January 26, 2005. It is in Health Canada’s list of active licences.
Licence number
67223
Licence holder
Roche Diagnostics GmbhMannheim, Germany
Risk class
Class II (low to moderate risk)
Licence type
Single Device
First licensed
January 26, 2005
Devices covered
1

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • INFORM CYTOPLASMIC LAMBDA MRNA PROBE

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.